nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Coronary artery disease—Vincristine—muscle cancer	0.0393	0.0393	CcSEcCtD
Alfuzosin—Neuropathy—Vincristine—muscle cancer	0.0146	0.0146	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Etoposide—muscle cancer	0.0143	0.0143	CcSEcCtD
Alfuzosin—Neuropathy—Etoposide—muscle cancer	0.0118	0.0118	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0114	0.0114	CcSEcCtD
Alfuzosin—Neuralgia—Doxorubicin—muscle cancer	0.00939	0.00939	CcSEcCtD
Alfuzosin—Laryngitis—Doxorubicin—muscle cancer	0.00905	0.00905	CcSEcCtD
Alfuzosin—Erectile dysfunction—Vincristine—muscle cancer	0.00897	0.00897	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00881	0.00881	CcSEcCtD
Alfuzosin—Pharyngitis—Dactinomycin—muscle cancer	0.00866	0.00866	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Vincristine—muscle cancer	0.00851	0.00851	CcSEcCtD
Alfuzosin—Sweating—Vincristine—muscle cancer	0.00833	0.00833	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00822	0.00822	CcSEcCtD
Alfuzosin—Flushing—Dactinomycin—muscle cancer	0.0081	0.0081	CcSEcCtD
Alfuzosin—Liver injury—Doxorubicin—muscle cancer	0.00775	0.00775	CcSEcCtD
Alfuzosin—Urinary tract disorder—Vincristine—muscle cancer	0.0077	0.0077	CcSEcCtD
Alfuzosin—Connective tissue disorder—Vincristine—muscle cancer	0.00766	0.00766	CcSEcCtD
Alfuzosin—Urethral disorder—Vincristine—muscle cancer	0.00764	0.00764	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00742	0.00742	CcSEcCtD
Alfuzosin—Cardiac disorder—Vincristine—muscle cancer	0.00724	0.00724	CcSEcCtD
Alfuzosin—Arthropathy—Doxorubicin—muscle cancer	0.00717	0.00717	CcSEcCtD
Alfuzosin—Angiopathy—Vincristine—muscle cancer	0.00707	0.00707	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dactinomycin—muscle cancer	0.00705	0.00705	CcSEcCtD
Alfuzosin—Infestation NOS—Etoposide—muscle cancer	0.00704	0.00704	CcSEcCtD
Alfuzosin—Infestation—Etoposide—muscle cancer	0.00704	0.00704	CcSEcCtD
Alfuzosin—Mediastinal disorder—Vincristine—muscle cancer	0.00703	0.00703	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Etoposide—muscle cancer	0.0069	0.0069	CcSEcCtD
Alfuzosin—Jaundice—Etoposide—muscle cancer	0.00686	0.00686	CcSEcCtD
Alfuzosin—Malaise—Dactinomycin—muscle cancer	0.00685	0.00685	CcSEcCtD
Alfuzosin—Mental disorder—Vincristine—muscle cancer	0.00683	0.00683	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Etoposide—muscle cancer	0.00665	0.00665	CcSEcCtD
Alfuzosin—Back pain—Vincristine—muscle cancer	0.00657	0.00657	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00652	0.00652	CcSEcCtD
Alfuzosin—Hepatocellular injury—Doxorubicin—muscle cancer	0.00652	0.00652	CcSEcCtD
Alfuzosin—Discomfort—Dactinomycin—muscle cancer	0.00639	0.00639	CcSEcCtD
Alfuzosin—Influenza like illness—Doxorubicin—muscle cancer	0.00634	0.00634	CcSEcCtD
Alfuzosin—Urinary tract disorder—Etoposide—muscle cancer	0.00624	0.00624	CcSEcCtD
Alfuzosin—Oedema—Dactinomycin—muscle cancer	0.0062	0.0062	CcSEcCtD
Alfuzosin—Urethral disorder—Etoposide—muscle cancer	0.00619	0.00619	CcSEcCtD
Alfuzosin—Infection—Dactinomycin—muscle cancer	0.00616	0.00616	CcSEcCtD
Alfuzosin—Neuropathy—Doxorubicin—muscle cancer	0.00612	0.00612	CcSEcCtD
Alfuzosin—Vertigo—Vincristine—muscle cancer	0.0061	0.0061	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00607	0.00607	CcSEcCtD
Alfuzosin—Eye disorder—Etoposide—muscle cancer	0.0059	0.0059	CcSEcCtD
Alfuzosin—Cardiac disorder—Etoposide—muscle cancer	0.00586	0.00586	CcSEcCtD
Alfuzosin—Flushing—Etoposide—muscle cancer	0.00586	0.00586	CcSEcCtD
Alfuzosin—Angiopathy—Etoposide—muscle cancer	0.00573	0.00573	CcSEcCtD
Alfuzosin—Mediastinal disorder—Etoposide—muscle cancer	0.00569	0.00569	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00565	0.00565	CcSEcCtD
Alfuzosin—Oedema—Vincristine—muscle cancer	0.00554	0.00554	CcSEcCtD
Alfuzosin—Infection—Vincristine—muscle cancer	0.0055	0.0055	CcSEcCtD
Alfuzosin—Osteoarthritis—Methotrexate—muscle cancer	0.00547	0.00547	CcSEcCtD
Alfuzosin—Nervous system disorder—Vincristine—muscle cancer	0.00543	0.00543	CcSEcCtD
Alfuzosin—Thrombocytopenia—Vincristine—muscle cancer	0.00542	0.00542	CcSEcCtD
Alfuzosin—Hyperhidrosis—Vincristine—muscle cancer	0.00536	0.00536	CcSEcCtD
Alfuzosin—Fatigue—Dactinomycin—muscle cancer	0.00535	0.00535	CcSEcCtD
Alfuzosin—Back pain—Etoposide—muscle cancer	0.00532	0.00532	CcSEcCtD
Alfuzosin—Pain—Dactinomycin—muscle cancer	0.0053	0.0053	CcSEcCtD
Alfuzosin—Hypotension—Vincristine—muscle cancer	0.00518	0.00518	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—muscle cancer	0.00511	0.00511	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—muscle cancer	0.0051	0.0051	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00507	0.00507	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00505	0.00505	CcSEcCtD
Alfuzosin—Malaise—Etoposide—muscle cancer	0.00496	0.00496	CcSEcCtD
Alfuzosin—Breast disorder—Methotrexate—muscle cancer	0.00494	0.00494	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—muscle cancer	0.00494	0.00494	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00492	0.00492	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—muscle cancer	0.0049	0.0049	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—muscle cancer	0.00483	0.00483	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00478	0.00478	CcSEcCtD
Alfuzosin—Fatigue—Vincristine—muscle cancer	0.00478	0.00478	CcSEcCtD
Alfuzosin—Constipation—Vincristine—muscle cancer	0.00474	0.00474	CcSEcCtD
Alfuzosin—Pain—Vincristine—muscle cancer	0.00474	0.00474	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—muscle cancer	0.00474	0.00474	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—muscle cancer	0.00468	0.00468	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00465	0.00465	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—muscle cancer	0.00462	0.00462	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vincristine—muscle cancer	0.00453	0.00453	CcSEcCtD
Alfuzosin—Infection—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—muscle cancer	0.00445	0.00445	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—muscle cancer	0.00439	0.00439	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00439	0.00439	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Alfuzosin—Abdominal pain—Vincristine—muscle cancer	0.00438	0.00438	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—muscle cancer	0.00436	0.00436	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—muscle cancer	0.00435	0.00435	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—muscle cancer	0.00434	0.00434	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00432	0.00432	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—muscle cancer	0.00432	0.00432	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—muscle cancer	0.00428	0.00428	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—muscle cancer	0.00424	0.00424	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—muscle cancer	0.00421	0.00421	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—muscle cancer	0.00421	0.00421	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—muscle cancer	0.00421	0.00421	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—muscle cancer	0.00419	0.00419	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—muscle cancer	0.00404	0.00404	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—muscle cancer	0.00399	0.00399	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—muscle cancer	0.00399	0.00399	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—muscle cancer	0.00399	0.00399	CcSEcCtD
Alfuzosin—Asthenia—Vincristine—muscle cancer	0.00397	0.00397	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—muscle cancer	0.00394	0.00394	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—muscle cancer	0.00394	0.00394	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—muscle cancer	0.00391	0.00391	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Alfuzosin—Pain—Etoposide—muscle cancer	0.00384	0.00384	CcSEcCtD
Alfuzosin—Constipation—Etoposide—muscle cancer	0.00384	0.00384	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.0038	0.0038	CcSEcCtD
Alfuzosin—Diarrhoea—Vincristine—muscle cancer	0.00379	0.00379	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—muscle cancer	0.00375	0.00375	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—muscle cancer	0.00371	0.00371	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—muscle cancer	0.0037	0.0037	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—muscle cancer	0.00368	0.00368	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—muscle cancer	0.00367	0.00367	CcSEcCtD
Alfuzosin—Dizziness—Vincristine—muscle cancer	0.00366	0.00366	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—muscle cancer	0.00365	0.00365	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—muscle cancer	0.00365	0.00365	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—muscle cancer	0.00365	0.00365	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—muscle cancer	0.00356	0.00356	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—muscle cancer	0.00355	0.00355	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—muscle cancer	0.00354	0.00354	CcSEcCtD
Alfuzosin—Vomiting—Vincristine—muscle cancer	0.00352	0.00352	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—muscle cancer	0.00351	0.00351	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Alfuzosin—Rash—Vincristine—muscle cancer	0.00349	0.00349	CcSEcCtD
Alfuzosin—Dermatitis—Vincristine—muscle cancer	0.00349	0.00349	CcSEcCtD
Alfuzosin—Headache—Vincristine—muscle cancer	0.00347	0.00347	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—muscle cancer	0.00343	0.00343	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—muscle cancer	0.00342	0.00342	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—muscle cancer	0.00341	0.00341	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—muscle cancer	0.00331	0.00331	CcSEcCtD
Alfuzosin—Nausea—Vincristine—muscle cancer	0.00329	0.00329	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—muscle cancer	0.00328	0.00328	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—muscle cancer	0.00317	0.00317	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—muscle cancer	0.00307	0.00307	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—muscle cancer	0.00297	0.00297	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—muscle cancer	0.00297	0.00297	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—muscle cancer	0.00296	0.00296	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—muscle cancer	0.00287	0.00287	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—muscle cancer	0.00285	0.00285	CcSEcCtD
Alfuzosin—Rash—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Alfuzosin—Headache—Etoposide—muscle cancer	0.00281	0.00281	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—muscle cancer	0.0028	0.0028	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—muscle cancer	0.0028	0.0028	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00278	0.00278	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Alfuzosin—Infection—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Alfuzosin—Nausea—Etoposide—muscle cancer	0.00267	0.00267	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—muscle cancer	0.00264	0.00264	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—muscle cancer	0.00263	0.00263	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—muscle cancer	0.0026	0.0026	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—muscle cancer	0.00251	0.00251	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—muscle cancer	0.00239	0.00239	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—muscle cancer	0.00237	0.00237	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Alfuzosin—Pain—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Alfuzosin—Rash—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Alfuzosin—Headache—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
